Research and experimental development on natural sciences and engineering
AKVAPROSJEKTER AS
Revenue 2024
NOK 0
Operating profit
NOK −16,000
Equity
NOK −639,000
Incorporated
2023
Share capital
NOK 100,000
Roles
Daglig lederIvar Gulla
Regnskapsfører
Styrets lederIvar Gulla
Shareholders
| Name | Stake | Shares | Year |
|---|---|---|---|
| GULLA HOLDING AS | 100.0% | 100000.000000 | 2025 |
Holdings in other companies
| Company | Status | Stake | Shares |
|---|---|---|---|
| BLÅ BIOTEK AS | Active | 100.0% | 150.000000 |
| PROPHYLAXIA AS | Active | 16.6% | 22526.000000 |
| PROPHYLAXIA SIGNS AS | Active | 10.2% | 15300.000000 |
| IRSEA ARC AS | Active | 10.0% | 20000.000000 |
| NORSK EDELFISK AS | Active | 0.9% | 2920.000000 |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.